Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Charles River Laboratories International leads the 115 health care companies ranked by P/E ratio, at 362, ahead of Takeda Pharmaceutical (304) and Waters (195). Figures as of 19 Nov 2026, 12:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- First
- Charles River Laboratories International362
- Median
- 30.7
- Combined market value
- AED 33.4T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Charles River Laboratories InternationalCRL · Health Care | 362 | AED 58.6B | AED 1,223.86 | 0.33% up | 106% up | ||
| 2 | Takeda PharmaceuticalTAK · Health Care | 304 | AED 249.6B | AED 78.11 | 1.71% down | 51% up | ||
| 3 | WatersWAT · Health Care | 195 | AED 336.4B | AED 1,711.75 | 3.63% up | 23% up | ||
| 4 | Merck & CoMRK · Health Care | 139 | AED 1.25T | AED 506.00 | 3.90% down | 45% up | ||
| 5 | Ligand PharmaceuticalsLGND · Health Care | 120 | AED 21.9B | AED 1,097.01 | 1.67% up | 50% up | ||
| 6 | BiogenBIIB · Health Care | 109 | AED 136.5B | AED 923.30 | 0.25% up | 49% up | ||
| 7 | BillionToOneBLLN · Health Care | 99.5 | AED 16.1B | AED 336.18 | 6.11% down | 4% down | ||
| 8 | TG TherapeuticsTGTX · Health Care | 98.7 | AED 36.7B | AED 242.83 | 5.44% up | 117% up | ||
| 9 | Teva Pharmaceutical IndustriesTEVA · Health Care | 98.2 | AED 181B | AED 155.09 | 0.92% down | 74% up | ||
| 10 | SolventumSOLV · Health Care | 97.2 | AED 54B | AED 317.60 | 0.49% up | 9% up | ||
| 11 | MedlineMDLN · Health Care | 89.0 | AED 189.3B | AED 143.82 | 3.93% up | 4% down | ||
| 12 | TeleflexTFX · Health Care | 81.7 | AED 24.2B | AED 609.08 | 3.95% up | 58% up | ||
| 13 | PenumbraPEN · Health Care | 80.8 | AED 46.4B | AED 1,177.40 | 0.47% up | 15% up | ||
| 14 | ICONICLR · Health Care | 78.1 | AED 53.7B | AED 716.73 | 0.07% up | 23% up | ||
| 15 | LifeStance Health GroupLFST · Health Care | 76.5 | AED 19.2B | AED 50.57 | 2.82% down | 123% up | ||
| 16 | Jazz PharmaceuticalsJAZZ · Health Care | 73.3 | AED 58.4B | AED 909.94 | 2.93% up | 41% up | ||
| 17 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 72.0 | AED 27.4B | AED 349.07 | 0.06% down | 129% up | ||
| 18 | HeartflowHTFL · Health Care | 68.5 | AED 14.8B | AED 168.53 | 2.51% down | 66% up | ||
| 19 | RevvityRVTY · Health Care | 67.7 | AED 62.5B | AED 559.80 | 3.14% up | 62% up | ||
| 20 | Bio-TechneTECH · Health Care | 66.7 | AED 42B | AED 267.17 | 0.17% up | 24% up | ||
| 21 | Edwards LifesciencesEW · Health Care | 61.2 | AED 222.2B | AED 386.46 | 0.19% down | 25% up | ||
| 22 | IncyteINCY · Health Care | 60.1 | AED 88.2B | AED 432.62 | 1.08% down | 16% up | ||
| 23 | AlconALC · Health Care | 54.9 | AED 132.8B | AED 276.39 | 1.55% up | 0% up | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 54.7 | AED 28B | AED 80.35 | 3.60% up | 90% up | ||
| 25 | HaemoneticsHAE · Health Care | 54.4 | AED 20.5B | AED 451.20 | 1.60% up | 64% up | ||
| 26 | BeOne MedicinesONC · Health Care | 51.7 | AED 169.3B | AED 1,482.22 | 2.34% down | 16% up | ||
| 27 | Corcept TherapeuticsCORT · Health Care | 51.0 | AED 27.2B | AED 248.96 | 3.25% down | 10% down | ||
| 28 | Intuitive SurgicalISRG · Health Care | 50.9 | AED 535.9B | AED 1,545.94 | 2.23% down | 24% down | ||
| 29 | AbbVieABBV · Health Care | 49.1 | AED 1.86T | AED 1,050.37 | 2.33% down | 25% up | ||
| 30 | BrightSpring Health ServicesBTSG · Health Care | 48.5 | AED 49.9B | AED 250.98 | 2.13% down | 109% up | ||
| 31 | IDEXX LaboratoriesIDXX · Health Care | 47.1 | AED 202.1B | AED 2,565.13 | 1.19% up | 1% up | ||
| 32 | West Pharmaceutical ServicesWST · Health Care | 45.3 | AED 103.4B | AED 1,483.76 | 2.44% down | 57% up | ||
| 33 | Royalty PharmaRPRX · Health Care | 44.9 | AED 145B | AED 252.19 | 0.01% down | 79% up | ||
| 34 | Eli LillyLLY · Health Care | 44.9 | AED 4.52T | AED 5,078.15 | 2.32% down | 33% up | ||
| 35 | GenmabGMAB · Health Care | 43.6 | AED 115.4B | AED 187.19 | 1.91% down | 70% up | ||
| 36 | Krystal BiotechKRYS · Health Care | 42.8 | AED 34.3B | AED 1,158.09 | 5.62% up | 54% up | ||
| 37 | Becton, DickinsonBDX · Health Care | 42.7 | AED 216.2B | AED 793.55 | 0.31% up | 45% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.6 | AED 45.9B | AED 55.01 | 1.28% up | 8% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | 41.4 | AED 2.41T | AED 1,001.49 | 2.15% down | 34% up | ||
| 40 | PfizerPFE · Health Care | 40.1 | AED 587.4B | AED 103.05 | 1.44% down | 15% up | ||
| 41 | Abbott LaboratoriesABT · Health Care | 39.0 | AED 664.6B | AED 383.70 | 0.22% down | 16% down | ||
| 42 | DanaherDHR · Health Care | 37.8 | AED 590.6B | AED 839.46 | 1.24% up | 3% up | ||
| 43 | Mettler-Toledo InternationalMTD · Health Care | 37.7 | AED 126.9B | AED 6,380.09 | 1.42% up | 24% up | ||
| 44 | HumanaHUM · Health Care | 37.6 | AED 170.2B | AED 1,416.78 | 12.98% down | 73% up | ||
| 45 | Thermo Fisher ScientificTMO · Health Care | 36.5 | AED 942.6B | AED 2,544.09 | 0.87% up | 21% up | ||
| 46 | IlluminaILMN · Health Care | 36.1 | AED 116.6B | AED 771.26 | 3.65% up | 76% up | ||
| 47 | Cardinal HealthCAH · Health Care | 36.0 | AED 236.3B | AED 1,022.13 | 0.33% down | 34% up | ||
| 48 | Medpace HoldingsMEDP · Health Care | 35.9 | AED 66.5B | AED 2,375.63 | 0.95% down | 10% up | ||
| 49 | HealthEquityHQY · Health Care | 35.1 | AED 29.6B | AED 357.37 | 4.45% down | 3% down | ||
| 50 | Agilent TechnologiesA · Health Care | 35.0 | AED 183.6B | AED 651.24 | 2.97% up | 22% up | ||
| 51 | Vertex PharmaceuticalsVRTX · Health Care | 34.5 | AED 499.5B | AED 1,970.11 | 0.42% up | 27% up | ||
| 52 | StrykerSYK · Health Care | 33.9 | AED 444.8B | AED 1,168.41 | 0.19% up | 12% down | ||
| 53 | argenxARGX · Health Care | 32.6 | AED 217.4B | AED 3,456.74 | 0.66% down | 2% up | ||
| 54 | DexComDXCM · Health Care | 32.5 | AED 113B | AED 303.05 | 0.59% up | 41% up | ||
| 55 | Merit Medical SystemsMMSI · Health Care | 32.2 | AED 18.9B | AED 315.58 | 1.70% up | 1% up | ||
| 56 | IQVIA HoldingsIQV · Health Care | 31.4 | AED 156.1B | AED 946.92 | 0.09% up | 19% up | ||
| 57 | STERISSTE · Health Care | 30.8 | AED 92.6B | AED 953.27 | 0.84% up | 1% up | ||
| 58 | AvantorAVTR · Health Care | 30.7 | AED 38.2B | AED 56.45 | 1.25% up | 40% up | ||
| 59 | Labcorp HoldingsLH · Health Care | 30.4 | AED 110.6B | AED 1,361.69 | 0.69% up | 42% up | ||
| 60 | NovartisNVS · Health Care | 29.6 | AED 1.08T | AED 570.01 | 2.46% down | 25% up | ||
| 61 | McKessonMCK · Health Care | 28.0 | AED 459.8B | AED 3,982.57 | 0.66% down | 28% up | ||
| 62 | Ensign GroupENSG · Health Care | 27.2 | AED 39.2B | AED 671.99 | 1.63% down | 2% up | ||
| 63 | LivaNovaLIVN · Health Care | 27.1 | AED 19.1B | AED 347.20 | 2.85% up | 77% up | ||
| 64 | Protagonist TherapeuticsPTGX · Health Care | 26.9 | AED 30.5B | AED 467.00 | 2.00% up | 51% up | ||
| 65 | QiagenQGEN · Health Care | 26.8 | AED 37.6B | AED 182.01 | 0.38% down | 9% up | ||
| 66 | PACS GroupPACS · Health Care | 26.3 | AED 27B | AED 170.04 | 4.63% down | 77% up | ||
| 67 | ChemedCHE · Health Care | 26.2 | AED 26B | AED 2,007.83 | 0.01% down | 27% up | ||
| 68 | Zimmer Biomet HoldingsZBH · Health Care | 26.1 | AED 71.8B | AED 379.44 | 1.20% up | 16% up | ||
| 69 | Koninklijke PhilipsPHG · Health Care | 25.9 | AED 107B | AED 109.48 | 0.27% down | 12% up | ||
| 70 | Quest DiagnosticsDGX · Health Care | 25.9 | AED 104.9B | AED 953.71 | 1.30% up | 38% up | ||
| 71 | AmgenAMGN · Health Care | 25.7 | AED 881.8B | AED 1,630.19 | 3.07% down | 32% up | ||
| 72 | Lantheus HoldingsLNTH · Health Care | 25.4 | AED 24.5B | AED 374.59 | 0.20% up | 90% up | ||
| 73 | AstraZenecaAZN · Health Care | 25.3 | AED 1.02T | AED 656.50 | 1.93% down | 1% up | ||
| 74 | Concentra Group Holdings ParentCON · Health Care | 24.8 | AED 19.4B | AED 154.17 | 0.94% down | 116% up | ||
| 75 | MedtronicMDT · Health Care | 24.7 | AED 473.1B | AED 369.89 | 1.56% down | 1% up | ||
| 76 | Neurocrine BiosciencesNBIX · Health Care | 24.2 | AED 60.5B | AED 598.10 | 1.84% down | 17% up | ||
| 77 | Halozyme TherapeuticsHALO · Health Care | 23.9 | AED 40.1B | AED 351.83 | 0.18% down | 39% up | ||
| 78 | Align TechnologyALGN · Health Care | 23.9 | AED 42.4B | AED 602.14 | 0.31% up | 23% up | ||
| 79 | Henry ScheinHSIC · Health Care | 23.5 | AED 34.8B | AED 314.70 | 3.32% up | 20% up | ||
| 80 | SanofiSNY · Health Care | 23.4 | AED 415.5B | AED 173.05 | 0.86% down | 4% down | ||
| 81 | CenteneCNC · Health Care | 23.2 | AED 122.6B | AED 247.71 | 7.03% down | 94% up | ||
| 82 | Option Care HealthOPCH · Health Care | 23.0 | AED 17.4B | AED 116.45 | 0.25% up | 12% up | ||
| 83 | InsuletPODD · Health Care | 22.9 | AED 35.7B | AED 514.08 | 3.69% down | 55% down | ||
| 84 | MSA SafetyMSA · Health Care | 22.8 | AED 25.1B | AED 651.69 | 2.67% up | 16% up | ||
| 85 | ResMedRMD · Health Care | 22.1 | AED 125.3B | AED 890.99 | 2.00% up | 1% down | ||
| 86 | United TherapeuticsUTHR · Health Care | 21.8 | AED 90.3B | AED 2,120.28 | 1.16% down | 22% up | ||
| 87 | Encompass HealthEHC · Health Care | 21.6 | AED 48.6B | AED 495.53 | 2.14% down | 20% up | ||
| 88 | Regeneron PharmaceuticalsREGN · Health Care | 20.9 | AED 359.2B | AED 3,472.46 | 1.28% down | 28% up | ||
| 89 | Cooper CompaniesCOO · Health Care | 20.9 | AED 42.4B | AED 223.10 | 0.05% up | 15% down | ||
| 90 | Smith & NephewSNN · Health Care | 20.6 | AED 46.6B | AED 111.35 | 0.62% down | 5% down | ||
| 91 | ExelixisEXEL · Health Care | 20.4 | AED 61.2B | AED 250.80 | 0.31% down | 63% up | ||
| 92 | UnitedHealth GroupUNH · Health Care | 20.0 | AED 1.15T | AED 1,285.04 | 10.21% down | 12% up | ||
| 93 | CencoraCOR · Health Care | 19.4 | AED 244.1B | AED 1,279.17 | 0.64% down | 4% down | ||
| 94 | Boston ScientificBSX · Health Care | 18.4 | AED 232.3B | AED 160.27 | 1.42% up | 55% down | ||
| 95 | Ascendis PharmaASND · Health Care | 17.8 | AED 65.1B | AED 992.79 | 0.32% down | 29% up | ||
| 96 | GE HealthCare TechnologiesGEHC · Health Care | 17.7 | AED 138.9B | AED 307.24 | 2.22% up | 12% up | ||
| 97 | Globus MedicalGMED · Health Care | 17.4 | AED 34.3B | AED 259.02 | 0.77% up | 14% down | ||
| 98 | Elevance HealthELV · Health Care | 17.0 | AED 318.1B | AED 1,472.08 | 7.63% down | 28% up | ||
| 99 | GSKGSK · Health Care | 16.9 | AED 357.6B | AED 178.41 | 1.34% down | 5% up | ||
| 100 | HCA HealthcareHCA · Health Care | 15.8 | AED 365.4B | AED 1,749.40 | 4.96% down | 0% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6725 AED). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/E ratio?
Charles River Laboratories International (362), Takeda Pharmaceutical (304) and Waters (195) are the top three of the 115 health care companies ranked by P/E ratio as of 19 Nov 2026, 12:02 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of AED 33.4T as of 19 Nov 2026, 12:02 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.